GlassScriptPhysician profile
Alfred Chamberlain Hurley
NPI 1316258528
$7,827.01
in general payments reported to CMS, 2019-2025
30 companies · $3,075 in 2025
The $3,075 reported for 2025 was more than what 75% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $589 · 2020: $270 · 2021: $318 · 2022: $599 · 2023: $325 · 2024: $2,651 · 2025: $3,075.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $4,800 · Food and Beverage: $1,251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $4,800.00 |
| Food and Beverage | $1,250.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $4,800.00 | 2024-2025 | Venacure 1470 Pro |
| Bard Peripheral Vascular, INC. | $602.10 | 2020-2025 | Venovo, Venclose Maven Catheter |
| Astrazeneca Pharmaceuticals LP | $443.68 | 2019-2022 | |
| Boston Scientific Corporation | $250.08 | 2020-2023 | Eluvia |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $240.63 | 2019-2023 | Lifevest |
| Becton, Dickinson and Company | $236.29 | 2025 | Venovo |
| Philips North America LLC | $127.15 | 2023-2025 | Igt Devices Systems Undivided |
| Chiesi USA, INC. | $122.70 | 2019-2022 | |
| Amgen INC. | $115.50 | 2019-2022 | |
| Cardiovascular Systems INC. | $95.06 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $90.19 | 2019-2020 | |
| Abbott Laboratories | $76.64 | 2019-2023 | Diamondback Peripheral |
| Pfizer INC. | $69.55 | 2020-2025 | |
| Tactile Systems Technology INC | $62.14 | 2024-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| E.R. Squibb & Sons, L.L.C. | $61.15 | 2019-2023 | Camzyos |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $55.45 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $52.85 | 2019-2023 | Jardiance |
| Novartis Pharmaceuticals Corporation | $41.57 | 2020-2023 | |
| Novo Nordisk INC | $39.57 | 2022 | |
| Nevro Corp. | $39.34 | 2023-2024 | Senza |
| Cashflow Solutions, LLC | $33.40 | 2024-2025 | Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White |
| Medtronic, INC. | $32.82 | 2021 | |
| Merck Sharp & Dohme LLC | $32.36 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $18.38 | 2019 | |
| Irhythm Technologies, INC. | $17.90 | 2022 | |
| Amarin Pharma, INC. | $16.97 | 2019 | |
| Opsens INC. | $15.47 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $13.98 | 2019 | |
| Biosense Webster, INC. | $12.32 | 2021 | |
| Teleflex LLC | $11.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alfred Hurley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.